Wells Fargo’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-28,214
| Closed | -$8.93M | – | 7198 |
|
|
2023
Q4 | $8.93M | Sell |
28,214
-9,534
| -25% | -$3.02M | ﹤0.01% | 1625 |
|
|
2023
Q3 | $6.38M | Buy |
37,748
+1,679
| +5% | +$284K | ﹤0.01% | 1802 |
|
|
2023
Q2 | $7.82M | Sell |
36,069
-3,720
| -9% | -$807K | ﹤0.01% | 1701 |
|
|
2023
Q1 | $7.23M | Buy |
39,789
+19,271
| +94% | +$3.5M | ﹤0.01% | 1725 |
|
|
2022
Q4 | $4.03M | Buy |
20,518
+5,247
| +34% | +$1.03M | ﹤0.01% | 2112 |
|
|
2022
Q3 | $3.44M | Buy |
15,271
+10,557
| +224% | +$2.37M | ﹤0.01% | 2158 |
|
|
2022
Q2 | $596K | Sell |
4,714
-9,437
| -67% | -$1.19M | ﹤0.01% | 3432 |
|
|
2022
Q1 | $1.8M | Sell |
14,151
-7,355
| -34% | -$933K | ﹤0.01% | 3203 |
|
|
2021
Q4 | $2.82M | Buy |
21,506
+10,700
| +99% | +$1.4M | ﹤0.01% | 2969 |
|
|
2021
Q3 | $1.32M | Buy |
10,806
+4,472
| +71% | +$547K | ﹤0.01% | 3801 |
|
|
2021
Q2 | $723K | Sell |
6,334
-2,742
| -30% | -$313K | ﹤0.01% | 4170 |
|
|
2021
Q1 | $1.09M | Sell |
9,076
-10,117
| -53% | -$1.22M | ﹤0.01% | 3925 |
|
|
2020
Q4 | $1.95M | Buy |
19,193
+1,772
| +10% | +$180K | ﹤0.01% | 3473 |
|
|
2020
Q3 | $1.35M | Buy |
17,421
+2,553
| +17% | +$197K | ﹤0.01% | 3565 |
|
|
2020
Q2 | $1.66M | Buy |
14,868
+4,571
| +44% | +$509K | ﹤0.01% | 3347 |
|
|
2020
Q1 | $742K | Buy |
10,297
+8,274
| +409% | +$596K | ﹤0.01% | 3642 |
|
|
2019
Q4 | $152K | Sell |
2,023
-2,745
| -58% | -$206K | ﹤0.01% | 4934 |
|
|
2019
Q3 | $78K | Buy |
+4,768
| New | +$78K | ﹤0.01% | 5169 |
|